People living with Type 2 Diabetes are at a significantly higher risk for cardiovascular events (such as heart attack and stroke) and kidney disease.
Our clinical research study is currently underway in our area and needs qualified participants. This study will be assessing the efficacy of a new investigational medication and its potential to prevent major adverse cardiovascular events in those with Type 2 Diabetes.
Locations in Bowling Green and Owensboro.